Dear Editor,
I am very concerned that our representatives in Congress are considering price-setting policies like HR3.
Such legislation not only represents dangerous political overreach; it also hurts patients. Today, America leads the world in innovation. We have unprecedented access to the latest medicines. But under HR3, this availability could drop from 86 percent to 52 percent.
Our biopharmaceutical industry has already shown the entire world – many times over – what they’re capable of. In the past several decades, researchers have made incredible advancements in treating various diseases. Not to mention the development and rollout of COVID-19 vaccinations. And their work is only getting started. Every day, scientists are developing life-saving therapies through new medical breakthroughs.
But price-setting laws could put an end to this innovation – and that’s the last thing we need right now. Instead, legislators need to give scientists the chance to build on the momentum of the past year. Our government needs to be supportive of medical progress, especially after all that has happened in 2020.
Sincerely,
Aaron Miller
